![Paul B. Knight](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul B. Knight
Direttore/Membro del Consiglio presso Molecular Diagnostics & Therapeutics, Inc.
Profilo
Paul B.
Knight has been a Director of Molecular Diagnostics & Therapeutics, Inc. since August 2000.
He is President of Transwestern Financial Advisors.
Mr. Knight has experience in capital management, financial forecasting, preparation of financial statements, and overseeing SEC filings and requirements
Posizioni attive di Paul B. Knight
Società | Posizione | Inizio |
---|---|---|
Molecular Diagnostics & Therapeutics, Inc.
![]() Molecular Diagnostics & Therapeutics, Inc. Medical SpecialtiesHealth Technology Molecular Diagnostics & Therapeutics, Inc. manufactures and distributes nuclear medicines. Its products include sodium iodide, palladium, thallium, thallous chloride, technetium and pet products. The company on February 19, 1992 and is headquartered in Longmont, CO. | Direttore/Membro del Consiglio | 01/08/2000 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Molecular Diagnostics & Therapeutics, Inc.
![]() Molecular Diagnostics & Therapeutics, Inc. Medical SpecialtiesHealth Technology Molecular Diagnostics & Therapeutics, Inc. manufactures and distributes nuclear medicines. Its products include sodium iodide, palladium, thallium, thallous chloride, technetium and pet products. The company on February 19, 1992 and is headquartered in Longmont, CO. | Health Technology |
- Borsa valori
- Insiders
- Paul B. Knight